is tirzepatide for type 2 diabetes (Mounjaro): A Dual-Action Breakthrough and Weight Loss Tirzepatide for Diabetes and Weight

Animal studies have shown that GLP-1 receptor activation reduces beta-amyloid plaque accumulation, potentially preventing the damage that leads to Alzheimers

Any movement shifts the liquid away from the optimal absorption zone and mixes it with saliva, diluting the concentration

Get started In clinical trials of the oral Wegovy (semaglutide) pill, participants taking the medication with diet and exercise achieved average weight loss of about 14%17% over ~64 weeks compared with ~2% with placebo

10.1038/npp.2016.246 [DOI] [PMC free article] [PubMed] [Google Scholar] Alhadeff A

This is especially important because a lot of people carrying extra weight also have excess fat built up in and around the liver (sometimes called fatty liver), which can cause its own health problems

Secondly, Tirzepatide promotes weight loss, a critical aspect of diabetes management